Amgen Inc. (AMGN)
Amgen Statistics
Share Statistics
Amgen has 537.21M shares outstanding. The number of shares has increased by 0.3% in one year.
Shares Outstanding | 537.21M |
Shares Change (YoY) | 0.3% |
Shares Change (QoQ) | 0.04% |
Owned by Institutions (%) | 77.57% |
Shares Floating | 535.99M |
Failed to Deliver (FTD) Shares | 143 |
FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is 11.43M, so 2.13% of the outstanding shares have been sold short.
Short Interest | 11.43M |
Short % of Shares Out | 2.13% |
Short % of Float | 2.13% |
Short Ratio (days to cover) | 3.15 |
Valuation Ratios
The PE ratio is 34.48 and the forward PE ratio is 13.46. Amgen's PEG ratio is -0.87.
PE Ratio | 34.48 |
Forward PE | 13.46 |
PS Ratio | 4.22 |
Forward PS | 4.3 |
PB Ratio | 23.99 |
P/FCF Ratio | 13.57 |
PEG Ratio | -0.87 |
Enterprise Valuation
Amgen Inc. has an Enterprise Value (EV) of 207.76B.
EV / Earnings | 50.8 |
EV / Sales | 6.22 |
EV / EBITDA | 15.56 |
EV / EBIT | 28.62 |
EV / FCF | 19.99 |
Financial Position
The company has a current ratio of 1.26, with a Debt / Equity ratio of 10.23.
Current Ratio | 1.26 |
Quick Ratio | 0.95 |
Debt / Equity | 10.23 |
Total Debt / Capitalization | 91.09 |
Cash Flow / Debt | 0.19 |
Interest Coverage | 2.3 |
Financial Efficiency
Return on equity (ROE) is 0.7% and return on capital (ROIC) is 9.76%.
Return on Equity (ROE) | 0.7% |
Return on Assets (ROA) | 0.04% |
Return on Capital (ROIC) | 9.76% |
Revenue Per Employee | $1,193,714.29 |
Profits Per Employee | $146,071.43 |
Employee Count | 28,000 |
Asset Turnover | 0.36 |
Inventory Turnover | 1.84 |
Taxes
Income Tax | 519M |
Effective Tax Rate | 0.11 |
Stock Price Statistics
The stock price has increased by 7.54% in the last 52 weeks. The beta is 0.52, so Amgen's price volatility has been higher than the market average.
Beta | 0.52 |
52-Week Price Change | 7.54% |
50-Day Moving Average | 299.89 |
200-Day Moving Average | 306.65 |
Relative Strength Index (RSI) | 45.77 |
Average Volume (20 Days) | 3.16M |
Income Statement
In the last 12 months, Amgen had revenue of 33.42B and earned 4.09B in profits. Earnings per share was 7.56.
Revenue | 33.42B |
Gross Profit | 20.57B |
Operating Income | 7.26B |
Net Income | 4.09B |
EBITDA | 13.36B |
EBIT | 7.26B |
Earnings Per Share (EPS) | 7.56 |
Balance Sheet
The company has 11.97B in cash and 60.1B in debt, giving a net cash position of -48.13B.
Cash & Cash Equivalents | 11.97B |
Total Debt | 60.1B |
Net Cash | -48.13B |
Retained Earnings | 0 |
Total Assets | 91.84B |
Working Capital | 5.93B |
Cash Flow
In the last 12 months, operating cash flow was 11.49B and capital expenditures -1.1B, giving a free cash flow of 10.39B.
Operating Cash Flow | 11.49B |
Capital Expenditures | -1.1B |
Free Cash Flow | 10.39B |
FCF Per Share | 19.21 |
Margins
Gross margin is 61.53%, with operating and profit margins of 21.71% and 12.24%.
Gross Margin | 61.53% |
Operating Margin | 21.71% |
Pretax Margin | 13.79% |
Profit Margin | 12.24% |
EBITDA Margin | 39.96% |
EBIT Margin | 21.71% |
FCF Margin | 31.1% |
Dividends & Yields
AMGN pays an annual dividend of $11.51, which amounts to a dividend yield of 3.03%.
Dividend Per Share | $11.51 |
Dividend Yield | 3.03% |
Dividend Growth (YoY) | 5.78% |
Payout Ratio | 152.45% |
Earnings Yield | 2.47% |
FCF Yield | 6.33% |
Analyst Forecast
The average price target for AMGN is $324, which is 6% higher than the current price. The consensus rating is "Hold".
Price Target | $324 |
Price Target Difference | 6% |
Analyst Consensus | Hold |
Analyst Count | 22 |
Stock Splits
The last stock split was on Nov 22, 1999. It was a forward split with a ratio of 2:1.
Last Split Date | Nov 22, 1999 |
Split Type | forward |
Split Ratio | 2:1 |
Scores
Altman Z-Score | 1.9 |
Piotroski F-Score | 7 |